HMRI hosted ImmVirX raises $22 million for human trials

ImmVirX Pty Ltd has announced the successful completion of $22 million in fundraising, which will go towards the first human studies of its new cancer treatment. ImmVirX is a biotechnology company based at the Hunter Medical Research Institute (HMRI*) and is supported by the University of Newcastle Research Associates (TUNRA).

Giving existing drugs a second chance

Preventing the early onset of labour is vital in the fight against pre-term birth but unfortunately developing new drugs is a long and difficult process. Fortunately, there are already several well-studied existing drugs that are known to prevent early labour or stop labour once it has begun.

Flu tracking system captures COVID-19 impact

One of the largest crowd-sourced public health surveillance systems in the world, known for detecting the spread of influenza, has revealed the COVID-19 pandemic dramatically impacted the 2020 flu season.

Australian medical research community leads innovation for patients affected by respiratory conditions

World events have placed the spotlight on respiratory health like never before. From severe bushfires to COVID-19, Australians living with respiratory conditions continue to face new health pressures. Through the 2020/21 Investigator Sponsored Studies (ISS) program, GSK has committed a record of $6.9 million to continue supporting the health of Australians. More than 14 Australian […]

What is seitan? The vegan protein alternative going viral online

The trend towards vegetarian and vegan diets means more people are looking for meat-free protein alternatives. Enter seitan (pronounced say-tan), the latest food trend that’s going viral online. by Dr Kerith Duncanson- Accredited Practising Dietician. Originally featured in The Conversation.